Reportlinker Adds Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's new report, "Infectious Immunology Reagents, Instruments and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global infectious immunology market. The report provides market landscape, competitive landscape and market trends information on the infectious immunology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include hepatitis viruses, retroviruses, bacteriology and other viruses.
- Annualized market revenues data from 2003 to 2010, forecast forward for 7 years to 2017. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within infectious immunology market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include F. Hoffmann-La Roche Ltd, Qiagen N.V., Becton, Dickinson and Company, Gen-Probe Incorporated and Beckman Coulter.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the infectious immunology market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the infectious immunology market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global infectious immunology market and the factors shaping it.
1 Table of contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction and Overview 7
2.1 Introduction 7
2.2 GlobalData Report Guidance 7
3 Infectious Immunology Overview 8
4 Global Infectious Immunology: Market Characterization 9
4.1 Infectious Immunology Market, Global, Revenue ($m), Historic, 2003-2010 9
4.2 Infectious Immunology Market, Global, Revenue ($m), Forecast, 2010-2017 10
4.3 Infectious Immunology, Key Market Trends 11
4.3.1 Demand for Rapid Methods for the Molecular Diagnosis of the Infectious Diseases is Altering the Infectious Immunology Landscape 11
4.3.2 Microfluidic Systems for Pathogen Testing are Expected to find Increased Adoption in the Future 12
4.3.3 Point of Care Testing Technology is the Current Trend in the Infectious Immunology Market 12
4.3.4 Technological Advancements such as Nanotechnology and PNA Florescence in Situ Hybridization (FISH) is the Latest Technological Trend for Early Detection 13
4.3.5 Shift Towards Automation and Consolidation of Laboratories Expects to Gain Popularity amongst the Laboratories and IVD Manufacturers 13
4.4 Infectious Immunology, Market Dynamics 15
4.4.1 Market Drivers 15
4.4.2 Market Restraints 19
5 Global Infectious Immunology Market: Analysis By Segment 21
5.1 Hepatitis Viruses: Market Characterization 21
5.1.1 Hepatitis Viruses Market, Global, Revenue ($m), Historic, 2003-2010 21
5.1.2 Hepatitis Viruses Market, Global, Revenue ($m), Forecast 2010-2017 22
5.1.3 Hepatitis Viruses, Market Drivers 23
5.1.4 Hepatitis Viruses, Market Restraint: Social Factors Associated with Hepatitis Might Act as Deterrent 23
5.2 Retroviruses: Market Charaterization 24
5.2.1 Retroviruses Market, Global, Revenue ($m), Historic, 2003-2010 24
5.2.2 Retroviruses Market, Global, Revenue ($m), Forecast, 2010-2017 25
5.2.3 Retroviruses, Market Drivers: Increasing Prevalence of HIV Infection to Drive the Retroviruses Market 26
5.2.4 Retroviruses Devices, Market Restraint: Lack of Awareness of HIV Infection is a Barrier for Market Growth 26
5.3 Bacteriology: Market Charaterization 27
5.3.1 Bacteriology Market, Global, Revenue ($m), Historic, 2003-2010 27
5.3.2 Bacteriology Market, Global, Revenue ($m), Forecast, 2010-2017 28
5.3.3 Bacteriology, Market Driver: Emergence of Drug Resistant Infectious Strains is Expected to Lead to Higher Demand for Diagnostic Tests 29
5.3.4 Bacteriology, Market Restraint: Easy Replication of Consumables in Developing Economies Put Pricing Pressure on Multinational Players 29
5.4 Other Virology: Market Charaterization 30
5.4.1 Other Virology, Global, Revenue ($m), Historic, 2003-2010 30
5.4.2 Other Virology, Global, Revenue ($m), Forecast, 2010-2017 31
5.4.3 Other Virology, Market Drivers 32
5.4.4 Others Virology, Market Restraint: Shortage of Skilled Professionals is a Major Concern for Laboratories Handling Emerging Viral Infections 32
6 Infectious Immunology Market, by Country, Revenue ($m), 2002–2016 33
6.1 Global Infectious Immunology Market, Revenue by Country, 2002-2016 33
6.1.1 Infectious Immunology Market, US, Revenue ($m), Historic, 2003-2010 33
6.1.2 Infectious Immunology Market, US, Revenue ($m), Forecast, 2010-2017 35
6.1.3 Infectious Immunology Market, Canada, Revenue ($m), Historic, 2003-2010 36
6.1.4 Infectious Immunology Market, Canada, Revenue ($m), Forecast, 2010-2017 37
6.1.5 BInfectious Immunology Market, UK, Revenue ($m), Historic, 2003-2010 38
6.1.6 Infectious Immunology Market, UK, Revenue ($m), Forecast, 2010-2017 39
6.1.7 Infectious Immunology Market, Germany, Revenue ($m), Historic, 2003-2010 41
6.1.8 Infectious Immunology Market, Germany, Revenue ($m), Forecast, 2010-2017 42
6.1.9 Infectious Immunology Market, France, Revenue ($m), Historic, 2003-2010 43
6.1.10 Infectious Immunology Market, France, Revenue ($m), Forecast, 2010-2017 44
6.1.11 Infectious Immunology Market, Italy, Revenue ($m), Historic, 2003-2010 45
6.1.12 Infectious Immunology Market, Italy, Revenue ($m), Forecast, 2010-2017 46
6.1.13 Infectious Immunology Market, Spain, Revenue ($m), Historic, 2003-2010 47
6.1.14 Infectious Immunology Market, Spain, Revenue ($m), Forecast, 2010-2017 48
6.1.15 Infectious Immunology Market, Japan, Revenue ($m), Historic, 2003-2010 49
6.1.16 Infectious Immunology Market, Japan, Revenue ($m), Forecast, 2010-2017 50
6.1.17 Infectious Immunology Market, China, Revenue ($m), Historic, 2003-2010 51
6.1.18 Infectious Immunology Market, China, Revenue ($m), Forecast, 2010-2017 52
6.1.19 Infectious Immunology Market, India, Revenue ($m), Historic, 2003-2010 53
6.1.20 Infectious Immunology Market, India, Revenue ($m), Forecast, 2010-2017 54
6.1.21 Infectious Immunology Market, Australia, Revenue ($m), Historic, 2003-2010 55
6.1.22 BInfectious Immunology Market, Australia, Revenue ($m), Forecast, 2010-2017 56
6.1.23 Infectious Immunology Market, Brazil, Revenue ($m), Historic, 2003-2010 57
6.1.24 Infectious Immunology Market, Brazil, Revenue ($m), Forecast, 2010-2017 58
7 Global Infectious Immunology Market: Competitive Assessment 59
7.1 Infectious Immunology Market, Global, Key Company Shares (%), 2009 59
7.2 Infectious Immunology Market, Key Market Participants 60
7.2.1 F. Hoffmann-La Roche Ltd 60
7.2.2 Qiagen N.V. 64
7.2.3 Becton, Dickinson and Company 67
7.2.4 Gen-Probe Incorporated 70
7.2.5 Beckman Coulter 73
7.3 Key Infectious Immunology Devices in the Market 75
7.3.1 COBAS AmpliPrep/COBAS TaqMan HBV Test, Roche Diagnostics 75
7.3.2 COBAS AMPLICOR Chlamydia Trachomatis/Neisseria Gonorrhoeae (CT/NG) Test, Roche Diagnostics 75
7.3.3 digene HC2 CT/GC DNA Test, Qiazen NV 75
7.3.4 QIAamp Viral RNA, Qiazen NV 76
7.3.5 BD Max System, Becton, Dickinson and Company 76
7.3.6 APTIMA COMBO 2 Assay, Gen-Probe 76
7.3.7 ProFlu+ Assay, Gen-Probe 76
8 Infectious Immunology, Pipeline Assessment 77
8.1 Infectious Immunology, Pipeline Products, by Segment 77
8.2 List of Promising Infectious Immunology Products under Clinical Development 78
8.3 Profiles of Promising Infectious Immunology Products under Clinical Development 80
8.3.1 Seeplex FluA ACE Subtyping Test 80
8.3.2 Anyplex CT/NG Real-time Detection Assay 80
8.3.3 Seeplex MRSA ACE Detection Assay 81
8.3.4 APTIMA HPV Assay 81
8.3.5 ARCHITECT i4000SR Anti-HAV IgG Assay 83
8.3.6 Neo-Natal HIV Test 83
8.3.7 Multiplo Rapid HBV/HIV/HCV Antibody Test 84
8.3.8 DPP HIV 1/2 Screening Assay 84
8.3.9 Diagnostic Test-Cytomegalovirus 86
8.3.10 Artus CMV Assay 86
8.3.11 TessArray RM-Flu Test 88
8.3.12 LightCycler SeptiFast Test MGRADE 89
9 Global Infectious Immunology Market – M&A Landscape 91
9.1 Global Infectious Immunology Market – Deals Overview 91
9.2 Key Acquisitions in Infectious Immunology Market 93
9.2.1 Danaher to Acquire Beckman Coulter, Inc. for $83.50 per share or $6.8 billion 93
9.2.2 Thermo Fisher Scientific Completes Acquisition of Ahura Scientific 93
9.2.3 Fujirebio Acquires Innogenetics from Abbott Laboratories 93
9.2.4 Gen-Probe Completes Acquisition of Prodesse 94
9.2.5 Solvay Pharmaceuticals acquires Innogenetics 94
9.2.6 Abbott Laboratories Acquires Ibis Biosciences from Isis Pharmaceuticals 94
10 Appendix 95
10.1 Definitions 96
10.1.1 Infectious Immunology 96
10.2 Acronyms 96
10.3 Sources 99
10.4 Research Methodology 99
10.5 Secondary Research 99
10.6 Primary Research 100
10.7 Models 100
10.8 Forecasts 100
10.9 Expert Panels 101
10.10 GlobalData Consulting 101
10.11 Contact Us 101
10.12 Disclaimer 101
1.1 List of Tables
Table 1: Infectious Immunology Market, Global, Revenue ($m), 2003-2010 9
Table 2: Infectious Immunology Market, Global, Revenue ($m), 2010-2017 10
Table 3: Infectious Immunology, US, Number of Completed Laboratory Acquisitions, 2002–2008 14
Table 4: Hepatitis Viruses Market, Revenue ($m), 2003-2010 21
Table 5: Hepatitis Viruses Market, Revenue ($m), 2010-2017 22
Table 6: Retroviruses Market, Global, Revenue ($m), 2003-2010 24
Table 7: Retroviruses Market, Revenue ($m), 2010-2017 25
Table 8: Bacteriology Market, Revenue ($m), 2003-2010 27
Table 9: Bacteriology Market, Revenue ($m), 2010-2017 28
Table 10: Other Virology Market, Revenue ($m), 2003-2010 30
Table 11: Other Virology Market, Revenue ($m), 2010-2017 31
Table 12: Infectious Immunology Market, US, Revenue ($m), 2003-2010 33
Table 13: Infectious Immunology Market, US, Revenue ($m), 2010-2017 35
Table 14: Infectious Immunology Market, Canada, Revenue ($m), 2003-2010 36
Table 15: Infectious Immunology Market, Canada, Revenue ($m), 2010-2017 37
Table 16: Infectious Immunology Market, UK, Revenue ($m), 2003-2010 38
Table 17: Infectious Immunology Market, UK, Revenue ($m), 2010-2017 39
Table 18: Infectious Immunology Market, Germany, Revenue ($m), 2003-2010 41
Table 19: Infectious Immunology Market, Germany, Revenue ($m), 2010-2017 42
Table 20: Infectious Immunology Market, France, Revenue ($m), 2003-2010 43
Table 21: Infectious Immunology Market, France, Revenue ($m), 2010-2017 44
Table 22: Infectious Immunology Market, Italy, Revenue ($m), 2003-2010 45
Table 23: Infectious Immunology Market, Italy, Revenue ($m), 2010-2017 46
Table 24: Infectious Immunology Market, Spain, Revenue ($m), 2003-2010 47
Table 25: Infectious Immunology Market, Spain, Revenue ($m), 2010-2017 48
Table 26: Infectious Immunology Market, Japan, Revenue ($m), 2003-2010 49
Table 27: Infectious Immunology Market, Japan, Revenue ($m), 2010-2017 50
Table 28: Infectious Immunology Market, China, Revenue ($m), 2003-2010 51
Table 29: Infectious Immunology Market, China, Revenue ($m), 2010-2017 52
Table 30: Infectious Immunology Market, India, Revenue ($m), 2003-2010 53
Table 31: Infectious Immunology Market, India, Revenue ($m), 2010-2017 54
Table 32: Infectious Immunology Market, Australia, Revenue ($m), 2003-2010 55
Table 33: Infectious Immunology Market, Australia, Revenue ($m), 2010-2017 56
Table 34: Infectious Immunology Market, Brazil, Revenue ($m), 2003-2010 57
Table 35: Infectious Immunology Market, Brazil, Revenue ($m), 2010-2017 58
Table 36: Infectious Immunology Market, Global, Key Company Shares (%), 2009 59
Table 37: F. Hoffmann-La Roche Ltd, Marketed Products in Infectious Immunology Market, 2010 61
Table 38: F. Hoffmann-La Roche Ltd, Pipeline Products in Infectious Immunology Market, 2010 61
Table 39: Qiagen N.V., Key Marketed Products, 2010 64
Table 40: Qiagen N.V., Pipeline Products in Infectious Immunology Market, 2010 64
Table 41: Becton, Dickinson and Company, Key Marketed Products, 2010 67
Table 42: Becton, Dickinson and Company, Pipeline Products in Infectious Immunology Market, 2010 67
Table 43: Gen-Probe Incorporated, Key Marketed Products, 2010 70
Table 44: Gen-Probe Incorporated, Pipeline Products in Infectious Immunology Market, 2010 70
Table 45: Beckman Coulter, Key Marketed Products, 2010 73
Table 46: Beckman Coulter, Pipeline Products in Infectious Immunology Market, 2010 73
Table 47: List of Promising Retroviruses Products under Clinical Development, 2010 78
Table 48: List of Promising Hepatitis Viruses Products under Clinical Development, 2010 78
Table 49: List of Promising Bacteriology Products under Clinical Development, 2010 79
Table 50: List of Promising Other Virology Products under Clinical Development, 2010 79
Table 51: Seeplex FluA ACE Subtyping Test, Product Status, 2010 80
Table 52: Anyplex CT/NG Real-time Detection Assay, Product Status, 2010 80
Table 53: Seeplex MRSA ACE Detection Assay, 2010 81
Table 54: APTIMA HPV Assay, Product Status, 2010 81
Table 55: APTIMA HPV Assay - Comparison of Three High-risk HPV (HR-HPV) Testes on ASC Samples With Follow-up 82
Table 56: APTIMA HPV Assay - Does RNA Testing Detect Clinically Significant HPV Infection 82
Table 57: ARCHITECT i4000SR Anti-HAV IgG Assay, Product Status, 2010 83
Table 58: Neo-Natal HIV Test, Product Status, 2010 83
Table 59: Multiplo Rapid HBV/HIV/HCV Antibody Test, Product Status, 2010 84
Table 60: DPP HIV 1/2 Screening Assay, Product Status, 2010 84
Table 61: DPP HIV 1/2 Screening Assay - Study to Establish the Ability of the Chembio Diagnostics Systems, Inc. DPP HIV 1/2 Rapid Test to Qualitatively Detect the Presence of Antibodies Against HIV-1 in Oral Fluid, Whole Blood (Capillary and Venous), Serum and Plasma 85
Table 62: Diagnostic Test-Cytomegalovirus, Product Status, 2010 86
Table 63: Artus CMV Assay, Product Status, 2010 86
Table 64: Artus CMV Assay - Clinical Evaluation of the Artus CMV RG PCR Test 87
Table 65: TessArray RM-Flu Test, Product Status, 2010 88
Table 66: LightCycler SeptiFast Test MGRADE, Product Status, 2010 89
Table 67: LightCycler SeptiFast Test MGRADE - Value of the LightCycler SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients 89
Table 68: Infectious Immunology Market, Global, Mergers and Acquisitions, 2007–2010 91
1.2 List of Figures
Figure 1: Infectious Immunology, Market Segmentation 8
Figure 2: Infectious Immunology Market, Global, Revenue ($m), 2003-2010 9
Figure 3: Infectious Immunology Market, Global, Revenue ($m), 2010-2017 10
Figure 4: Number of Completed Laboratory Acquisitions, 2002–2008 14
Figure 5: Infectious Immunology, Market Drivers and Restraints 15
Figure 6: Hepatitis Viruses Market, Revenue ($m), 2003-2010 21
Figure 7: Hepatitis Viruses Market, Revenue ($m), 2010-2017 22
Figure 8: Retroviruses Market, Global, Revenue ($m), 2003-2010 24
Figure 9: Retroviruses Market, Revenue ($m), 2010-2017 25
Figure 10: Bacteriology Market, Revenue ($m), 2003-2010 27
Figure 11: Bacteriology Market, Revenue ($m), 2010-2017 28
Figure 12: Other Virology Market, Revenue ($m), 2003-2010 30
Figure 13: Other Virology Market, Revenue ($m), 2010-2017 31
Figure 14: Infectious Immunology Market, US, Revenue ($m), 2003-2010 33
Figure 15: Infectious Immunology Market, US, Revenue ($m), 2010-2017 35
Figure 16: Infectious Immunology Market, Canada, Revenue ($m), 2003-2010 36
Figure 17: Infectious Immunology Market, Canada, Revenue ($m), 2010-2017 37
Figure 18: Infectious Immunology Market, UK, Revenue ($m), 2003-2010 38
Figure 19: Infectious Immunology Market, UK, Revenue ($m), 2010-2017 39
Figure 20: Infectious Immunology Market, Germany, Revenue ($m), 2003-2010 41
Figure 21: Infectious Immunology Market, Germany, Revenue ($m), 2010-2017 42
Figure 22: Infectious Immunology Market, France, Revenue ($m), 2003-2010 43
Figure 23: Infectious Immunology Market, France, Revenue ($m), 2010-2017 44
Figure 24: Infectious Immunology Market, Italy, Revenue ($m), 2003-2010 45
Figure 25: Infectious Immunology Market, Italy, Revenue ($m), 2010-2017 46
Figure 26: Infectious Immunology Market, Spain, Revenue ($m), 2003-2010 47
Figure 27: Infectious Immunology Market, Spain, Revenue ($m), 2010-2017 48
Figure 28: Infectious Immunology Market, Japan, Revenue ($m), 2003-2010 49
Figure 29: Infectious Immunology Market, Japan, Revenue ($m), 2010-2017 50
Figure 30: Infectious Immunology Market, China, Revenue ($m), 2003-2010 51
Figure 31: Infectious Immunology Market, China, Revenue ($m), 2010-2017 52
Figure 32: Infectious Immunology Market, India, Revenue ($m), 2003-2010 53
Figure 33: Infectious Immunology Market, India, Revenue ($m), 2010-2017 54
Figure 34: Infectious Immunology Market, Australia, Revenue ($m), 2003-2010 55
Figure 35: Infectious Immunology Market, Australia, Revenue ($m), 2010-2017 56
Figure 36: Infectious Immunology Market, Brazil, Revenue ($m), 2003-2010 57
Figure 37: Infectious Immunology Market, Brazil, Revenue ($m), 2010-2017 58
Figure 38: Infectious Immunology Market, Global, Key Company Shares (%), 2009 59
Figure 39: Infectious Immunology, Strategic Competitive Assessment, 2010 60
Figure 40: F. Hoffmann-La Roche Ltd, SWOT ANALYSIS, 2010 62
Figure 41: Qiagen N.V., SWOT Analysis, 2010 65
Figure 42: Becton, Dickinson and Company, SWOT Analysis 68
Figure 43: Gen-Probe Incorporated, SWOT Analysis, 2010 71
Figure 44: Beckman Coulter, SWOT Analysis, 2010 73
Figure 45: Infectious Immunology, Pipeline Products, by Segment, 2010 77
Figure 46: Infectious Immunology Market, Financial Deal Analysis-Deal Volume and Value, 2006-2010 91F. Hoffmann-La Roche Ltd
Qiagen N.V.
Becton, Dickinson and Company
Gen-Probe Incorporated
Beckman Coulter
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article